Highlights NP Inc.

Equities

A291230

KR7291230001

End-of-day quote Korea S.E. Other stock markets 03:30:00 20/05/2024 am IST			5-day change	1st Jan Change
2,940 ^KRW	+6.14%		+7.69%	-9.54%

03/04	Ultra Lithium Provides Bi-Weekly Default Status Report	MT
29/03	Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ultra Lithium Provides Bi-Weekly Default Status Report	03/04	MT
Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	29/03	MT
MCF Energy Acquires Accretive Czech Gas Projects with Immediate Production and Growth Potential	26/02	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD	31/01	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast	30/11	MT
Algernon Pharma in LOI For Acquisition of its Chronic Cough Research Program For US$2 Million and 20% Equity Stake	22/11	MT
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH	06/23/06	MT
Novelplus Technology Trims Loss in H1	15/23/15	MT
Algernon Pharmaceuticals Engage Maxim Group to Explore Spin-Off of Ifenprodil Phase 2 Chronic Cough Drug Development Program	27/23/27	MT
Algernon Pharmaceuticals Receives Notice of Allowance From Japanese Patent Office for Repirinast and Treatment of CKD	31/23/31	MT
NP Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Former UN chief Ban returns to Myanmar, meets ruling general	24/23/24	RE
Titan Medical Announcing Receipt of MCTO	04/23/04	MT
Keppel Philippines Properties Divesting 50% Stake in SM Keppel Land	27/23/27	MT
An Unknown buyer agreed to acquire 8.999% stake in NP Inc. from Wysiwyg Studios Co., Ltd. for KRW 30.7 billion.	15/23/15	CI
Algernon Pharmaceuticals Announces Plans for a 180 Patient Phase 2b Chronic Cough Study of Ifenprodil	09/23/09	MT
BeLive Technology Announces Partnership with NP Inc. to Offer Extended Reality Commerce	09/23/09	CI
Jaguar Health's Napo Pharmaceuticals to Start Early-Stage Trial for Diarrhea Drug Candidate	29/22/29	MT
Algernon Pharmaceuticals Files for Orphan Designation With the U.S. FDA for Ifenprodil as a Treatment of IPF	19/22/19	MT
Aehr Test Systems Says it Wins Order for Fox-NP, WaferPak Products From Semiconductor Customer; Shares Surge	13/22/13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NP Inc.

Equities

A291230

KR7291230001

Highlights

Filters